The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

127 citing papers in PubMed.

1. Targeting ferroptosis to overcome drug resistance in lung cancer.Translational lung cancer research · 2025
   Review
2. Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations.Signal transduction and targeted therapy · 2025
   Review
3. Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications.MedComm · 2025
   Review
4. Recent Advances in Anti-Cancer Drugs.International journal of molecular sciences · 2025
   Article
5. Tumor Cell-Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy.Cancer immunology research · 2025
   Article
6. Light-based technologies in immunotherapy: advances, mechanisms and applications.Immunotherapy · 2025
   Review
7. CAR-T cells in the treatment of multiple myeloma: an encouraging cell therapy.Frontiers in immunology · 2025
   Review
8. Advances in preclinical and clinical studies of oncolytic virus combination therapy.Frontiers in oncology · 2025
   Review
9. The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review.International journal of molecular sciences · 2024
   Review
10. Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.ACS nano · 2024
    Article
11. New insight in immunotherapy and combine therapy in colorectal cancer.Frontiers in cell and developmental biology · 2024
    Review
12. Ferroptosis and its relationship with cancer.Frontiers in cell and developmental biology · 2024
    Review
13. 10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer.Frontiers in oncology · 2024
    Review
14. Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy.Frontiers in immunology · 2024
    Article
15. Development and validation of an immune-related gene prognostic index for lung adenocarcinoma.Journal of thoracic disease · 2023
    Article
16. T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.Cancer immunology research · 2023
    Article
17. A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022.Cell death discovery · 2023
    Article
18. Clinical factors affecting the long-term survival of breast cancer patients.The Journal of international medical research · 2023
    Article
19. Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma.Frontiers in genetics · 2023
    Article
20. Knowledge mapping and current trends of global research on CRISPR in the field of cancer.Frontiers in cell and developmental biology · 2023
    Article

67 more citing papers are in PubMed but not listed here.

Corrections and comments

• Erratum for
  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.2016

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.